Tuesday Jul 09, 2024
INVOS™ technology overview pt 7: How is the algorithm developed for the pediatric population?
Eli Kuhlmann, Sr. Research Manager at Medtronic, describes how the INVOS™ system pediatric algorithm was developed in order to account for factors impacting regional oximetry measurements in pediatric patients. The INVOS™ monitoring system should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.